Locations:
SearchAdvertisement
Inhibition of DNA-PK suppresses tumor growth in preclinical models
APE2 may hold the key to reducing cisplatin toxicity
How inhibiting the H6PD protein may reverse drug resistance
Researchers develop a personalized genomic medicine platform to identify clinically actionable mutations
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
The molecular mechanisms that underlie fetal brain calcification caused by Zika virus infection
Researchers identify protector of intestinal barrier
Patient-derived model mirrors the disease’s complexity better than others currently available
A possible association between ACE2 and TMPRSS2 polymorphisms and COVID-19 susceptibility
Largest-to-date evaluation of germline mutations in this population demonstrates the value of genetics evaluation and genetic testing
Minimizing the translational gap between preclinical testing and clinical outcomes
Advertisement
Advertisement